BARDA

PharmAthene Receives 5M Initial Payment from SIGA

Health Security April 13, 2016

…

Pharma Manufacturing and Pandemic Preparedness

Biosecurity April 7, 2016

…

Measuring Radiation Exposure After Nuclear Emergency

Biodetection April 1, 2016

…

Phase 1 Trial Begins for IV Version of Smallpox Drug

Biosecurity March 23, 2016

…

FDA Approves New Injection for Inhalational Anthrax

Biosecurity March 21, 2016

…

BARDA Seeks Single Dose Anthrax Post-Exposure Vaccine

Contracts + Grants March 9, 2016

…

Anti-Bacterial Fabrics for Fight Against Superbugs

Antimicrobial Resistance March 6, 2016

…

ZMapp Trial Shows Signs of Efficacy, But Data Insufficient

Biosecurity February 24, 2016

…

SIGA Gets Greenlight on Smallpox Drug Phase 3 Trial

Biosecurity February 24, 2016

…

Antibiotic Resistant Bacteria Countermeasure Accelerator

Antimicrobial Resistance February 23, 2016

…

Government, Pharma Leaders to Gather at Superbugs & Superdrugs

Antimicrobial Resistance February 21, 2016

…

BARDA Seeks Advanced Public Health Consequence Modeling

Biosecurity February 21, 2016

…

Superbugs and Superdrugs: An Interview with BARDA

Antimicrobial Resistance February 2, 2016

…

Profectus BioSciences Initiates Ebola Vaccine Phase 1 Trial

Medical Countermeasures January 20, 2016

…

BARDA Selects UM SOM for Radiation Nuclear Animal Model Development

CBRNE January 18, 2016

…

New Study Highlights Bigger Threat of Burkholderia

Biodetection January 11, 2016

…

WRAIR Begins Ebola Vaccine Phase 2 Trial

Biosecurity January 6, 2016

…

U.S. Backs High-Speed Manufacturing of Masks for Pandemics

Biosecurity December 10, 2015

…

FDA Approves BioThrax for Post-Exposure Indication

Industry News November 30, 2015

…

HHS Adds New Anthrax Countermeasures to Stockpile

Biosecurity November 13, 2015

…